ZENLABS ETHICA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.1 INR | +1.52% |
|
+8.49% | +21.01% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 691M 8.28M 11.32M | Sales 2023 | 669M 8.02M 10.96M | Capitalization | 450M 5.39M 7.37M |
|---|---|---|---|---|---|
| Net income 2022 | 8M 95.87K 131K | Net income 2023 | 4M 47.94K 65.55K | EV / Sales 2022 | 0.3 x |
| Net Debt 2022 | 23.95M 287K 392K | Net Debt 2023 | 42.26M 506K 693K | EV / Sales 2023 | 0.74 x |
| P/E ratio 2022 |
22.6
x | P/E ratio 2023 |
92.1
x | Employees | 69 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 33.92% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.52% | ||
| 1 week | +8.49% | ||
| Current month | +9.39% | ||
| 1 month | +20.87% | ||
| 3 months | +5.10% | ||
| 6 months | +27.64% | ||
| Current year | +21.01% |
1 week
44.51
51.60
1 month
38.8551.60
Current year
38.8570.00
1 year
31.3070.00
3 years
23.0583.00
5 years
17.9083.00
10 years
6.79134.90
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 05-03-14 | |
Adarsh Sharma
DFI | Director of Finance/CFO | - | 23-07-27 |
Akshay Saxena
CMP | Compliance Officer | - | 23-07-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 05-03-14 | |
Him Jyoti
BRD | Director/Board Member | - | 15-03-24 |
Sanjay Dhir
BRD | Director/Board Member | 53 | 16-08-10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-06 | 50.1 | +1.52% | 39,239 |
| 24-05-03 | 49.35 | +5.00% | 39,672 |
| 24-05-02 | 47 | +2.62% | 29,445 |
| 24-04-30 | 45.8 | -0.82% | 13,344 |
Delayed Quote Bombay S.E., May 06, 2024 at 06:27 am
More quotes
Zenlabs Ethica Limited is an India-based marketing company. The Company is engaged in trading in a range of branded drugs, including gastrointestinal tract disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps and anti-bacterial drugs, nutraceuticals, and other. It has approximately five manufacturing units. It operates through three divisions: Zenlabs, Coles Pharma and Mega Star. Zenlabs division provides various products, including Analgesics & Anti-Inflammatory, Skin Preparations, Neurological Disorders, Eye, Ear and Nasal Drops, Anti-Diabetic, Anti-Depressant, Anti-Infective, Anti-Emetic, Steroid & Anabolic Steroid, Anti-Hypertensive Drugs, Anti Allergic, Anti Cold & Cough Syrup, Nutraceuticals, Antacid, Enzymes & Appetite Stimulant, Ayurvedic Preparation, GIT Disorders, Soap, and Other Pharmaceutical Drugs. Coles Pharma division provides various products, including Analgesics & Anti-Inflammatory, Nutraceuticals, Skin Preparations, and other.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +21.01% | 3.85M | |
| +15.21% | 69.5B | |
| -2.19% | 24.09B | |
| +8.13% | 8.2B | |
| -18.28% | 7.97B | |
| +0.24% | 7.84B | |
| +19.12% | 4.32B | |
| 0.00% | 4.19B | |
| -3.02% | 3.89B | |
| +23.97% | 3.62B |
- Stock Market
- Equities
- ZENLABS6 Stock